These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1052 related items for PubMed ID: 9378957
1. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression. Ishimoto T, Yamamoto K, Fukui Y, Fukuda Y, Dohi K, Sasazuki T. J Immunol; 1997 Oct 15; 159(8):3717-22. PubMed ID: 9378957 [Abstract] [Full Text] [Related]
2. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice. Henderson SC, Berezovskaya A, English A, Palliser D, Rock KL, Bamezai A. J Immunol; 1998 Jul 01; 161(1):175-82. PubMed ID: 9647222 [Abstract] [Full Text] [Related]
8. Identification of an HLA-DQ6-derived peptide recognized by mouse MHC class I H-2Db-restricted CD8+ T cells in HLA-DQ6 transgenic mice. Takeshita T, Fukui Y, Yamamoto K, Yamane K, Inamitsu T, Kamikawaji N, Sasazuki T. Jpn J Hum Genet; 1997 Mar 01; 42(1):225-32. PubMed ID: 9184003 [Abstract] [Full Text] [Related]
9. HLA-DR4 (DRB1*0401) transgenic mice expressing an altered CD4-binding site: specificity and magnitude of DR4-restricted T cell response. Pan S, Trejo T, Hansen J, Smart M, David CS. J Immunol; 1998 Sep 15; 161(6):2925-9. PubMed ID: 9743354 [Abstract] [Full Text] [Related]
10. CD4-negative cytotoxic T cells with a T cell receptor alpha/beta intermediate expression in CD8-deficient mice. Dalloul AH, Ngo K, Fung-Leung WP. Eur J Immunol; 1996 Jan 15; 26(1):213-8. PubMed ID: 8566069 [Abstract] [Full Text] [Related]
11. Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Kaye J, Hsu ML, Sauron ME, Jameson SC, Gascoigne NR, Hedrick SM. Nature; 1989 Oct 26; 341(6244):746-9. PubMed ID: 2571940 [Abstract] [Full Text] [Related]
14. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts. Dalloul AH, Chmouzis E, Ngo K, Fung-Leung WP. J Immunol; 1996 Jun 01; 156(11):4114-9. PubMed ID: 8666777 [Abstract] [Full Text] [Related]
15. Restricted expression of transgenic HLA-DRA gene in thymic epithelial cells and its role in acquisition of T cell tolerance to self-superantigens and processed DR alpha-derived peptide. Fukui Y, Yamamoto K, Yokoyama N, Iwanaga T, Kurashima C, Esaki Y, Kimura A, Akashi T, Hirokawa K, Sasazuki T. Eur J Immunol; 1993 Jul 01; 23(7):1678-86. PubMed ID: 8100779 [Abstract] [Full Text] [Related]
16. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules. Sone T, Tsukamoto K, Hirayama K, Nishimura Y, Takenouchi T, Aizawa M, Sasazuki T. J Immunol; 1985 Aug 01; 135(2):1288-98. PubMed ID: 3159789 [Abstract] [Full Text] [Related]
17. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules. Schmidt D, Amrani A, Verdaguer J, Bou S, Santamaria P. J Immunol; 1999 Apr 15; 162(8):4627-36. PubMed ID: 10202002 [Abstract] [Full Text] [Related]